Skip to main content
. 2016 Jul 16;22:797–815.

Table 1. Clinical characteristics of the patients screened for TULP1 mutations.

Family ID C-Age (Yr.) D-age(Yr.) First symptoms Night blindness Fundus examination Electroretinography
Visual acuity
OD OS OD OS
PKRP259
10
28
6
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/36
6/40
PKRP259
15
22
7
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/24
6/24
PKRP268
12
17
7
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/20
6/20
PKRP268
13
14
6
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/20
6/20
PKRP301
14
20
5
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/18
6/20
PKRP301
17
14
5
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/20
6/24
PKRP309
11
34
6
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/30
6/28
PKRP309
15
25
7
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/25
6/25
PKRP356
10
10
5
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/12
6/12
PKRP356
12
8
5
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/20
6/20
PKRP364
10
58
7
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/50
6/50
PKRP364
20
21
8
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/24
6/24
PKRP367
11
31
6
Night blindness
progressive
MD, Art. Atten, Pig.dep, PD
NAB, NF
NAB, NF
6/24
6/28
PKRP367 12 20 7 Night blindness progressive MD, Art. Atten, Pig.dep, PD NAB, NF NAB, NF 6/20 6/20

MD: macular degeneration; Art. Atten: artery attenuation; Pig.dep: pigment deposit; PD: Pale optic disc; NAB: no ‘a’ or ‘b’ wave response; NF: no flicker response; C-Age: current age; D-Age: age at first diagnosis of the retinal dystrophy.